Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-05

Clinical Trial Update: Brain Infusion of Muscimol to Treat Epilepsy [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating brain infusion of muscimol for epilepsy was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Muscimol (muscimol)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Epilepsy | Phase 1 | Status: TERMINATED